Shana Kelley

Neena B. Schwartz Professor of Chemistry and Biomedical Engineering

Education

Ph.D. California Institute of Technology (Chemistry)

Professional Appointments

2021 – present
Neena B. Schwartz Professor
Northwestern University, Departments of Chemistry, Biomedical Engineering and
Biochemistry & Molecular Genetics
International Institute for Nanotechnology
Simpson Querrey Institute
Lurie Cancer Cancer

2018 – present
University Professor
University of Toronto, Departments of Chemistry, Pharmaceutical Sciences, Biochemistry,
Institute for Biomaterials and Biomedical Engineering

2018 – 2021
Director
PRiME, A Precision Medicine Initiative at the University of Toronto

2007 – 2018
Professor
University of Toronto, Departments of Chemistry, Pharmaceutical Sciences, Biochemistry,
Institute for Biomaterials and Biomedical Engineering

2008 – 2011
Director
Division of Biomolecular Sciences, Faculty of Pharmacy
University of Toronto

2000 – 2006
Professor
Boston College, Department of Chemistry

1999 – 2000
NIH Postdoctoral Fellow
Scripps Research Institute, Department of Cell and Molecular Biology

Selected Professional Activities

Co-founder and Board Director, Arma Biosciences, 2020 – present
Co-founder and Board Director, CTRL Therapeutics, 2019 – present
Director, PRiME, A Precision Medicine Initiative, 2019 – 2022
Theme Leader, Nanomedicines Innovation Network (NMIN), 2019 – 2021
Scientific Advisory Board, Sartorius AG, 2019 – present
Scientific Advisory Committee, CNM, Argonne National Laboratory , 2018 – present
Board Director, Ontario Genomics, 2017 – 2020
Board Trustee, Fight Against Cancer Trust, 2017 – present
Editorial Advisory Board, ACS Chemical Biology, 2017 – present
Editorial Advisory Board, Journal of the American Chemical Society, 2016 – present
Executive Leadership Team, Medicine by Design (CFREF), 2016 – 2022
Panel Member, NIH ISD panel, 2016 – 2021
Associate Editor, ACS Sensors, 2015 – present
Program Committee, ACS Biological Chemistry Div., 2016 – 2020
Co-Founder and Board Director, Xagenic Inc., 2010 – 2017 (acquired by General Atomics)
Co-Founder, GeneOhm Sciences, 2000 – 2006 (acquired by Becton Dickinson)

Awards & Honours

2022 Guggenheim Fellow
2022 ACS Arthur K. Doolittle Award (PMSE)
2021 Fellow, Royal Society of Canada
2021 Order of Ontario
2020 AFPC Pfizer Award
2018 Distinguished Visiting Fellow, Rowland Institute, Harvard University
2017 ACS Nanoscience Award
2017 Somorjai Visiting Miller Professorship (UC Berkeley)
2016 SLAS Innovation Award
2016 NSERC Brockhouse Award
2016 Fellow, American Institute for Medical and Biological Engineering
2016 Fellow, Canadian Academy of Health Sciences
2013 University of Toronto Distinguished Professor Award
2011 Steacie Prize
2011 University of Toronto Inventor of the Year
2010 NSERC E.W.R Steacie Fellowship
2008 Named one of “Canada’s Top 40 under 40” by Globe & Mail/Caldwell Part
2006 Pittsburgh Conference Achievement Award
2005 Camille Drefus Teacher-Scholar Award
2004 TR100: Voted one of the top 100 innovators by Technology Review Magazine
2004 Alfred P. Sloan Fellowship
2004 NSF CAREER Award
2000 Dreyfus New Faculty Award
2000 Research Innovation Award